Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. 4 Shares withheld for taxes President and CEO gave up 863 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Financial Officer gave up 370 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Scientific Officer gave up 370 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Legal Officer gave up 493 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Reg & Develop Officer gave up 357 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Commercial Officer gave up 288 shares (to pay taxes)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy Director bought 372,093 shares at $10.75 ($4,000,000)
  9. 4 Open-market buy Director bought 7,100 shares at $14.00 ($99,370)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market buy Director bought 6,600 shares at $15.00 ($98,985)
  12. 4 Open-market buy Director bought 6,250 shares at $15.97 ($99,813)
  13. 4 Open-market sale Chief Legal Officer sold 5,000 shares at $20.00 ($100,000)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale Chief Legal Officer sold 10,000 shares at $20.00 ($200,000)
  20. 4 Open-market buy Director bought 500 shares at $19.12 ($9,560)

Page 15 of 21 · 414 filings